These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 30709723)
1. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015. Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723 [TBL] [Abstract][Full Text] [Related]
2. Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021. Gao D; Dong G; Zhu L; Jia N; Sun B Hum Vaccin Immunother; 2023 Aug; 19(2):2263225. PubMed ID: 37782096 [TBL] [Abstract][Full Text] [Related]
3. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010]. Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620 [TBL] [Abstract][Full Text] [Related]
4. Annual report: surveillance of adverse events following immunisation in Australia, 2008. Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966 [TBL] [Abstract][Full Text] [Related]
5. Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experience. Singh AK; Wagner AL; Joshi J; Carlson BF; Aneja S; Boulton ML Expert Rev Vaccines; 2018 Jun; 17(6):555-562. PubMed ID: 29865876 [TBL] [Abstract][Full Text] [Related]
6. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017. Masuka JT; Khoza S BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314 [TBL] [Abstract][Full Text] [Related]
7. [Analysis on death from adverse event following immunization surveillance system of Shandong Province during 2011-2016]. Zhang YJ Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):723-727. PubMed ID: 28763922 [No Abstract] [Full Text] [Related]
8. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China. Guo B; Page A; Wang H; Taylor R; McIntyre P Vaccine; 2013 Jan; 31(4):603-17. PubMed ID: 23200940 [TBL] [Abstract][Full Text] [Related]
9. Analysis of deaths following yeast-derived hepatitis B vaccination of infants, China, January 2013 to December 2020. Zhang S; Zhao T; Chen L; Xie M; Lu QB; Du J; Zeng J; Huang N; Liu Y; Wang C; Cui F Front Public Health; 2023; 11():1170483. PubMed ID: 37397780 [TBL] [Abstract][Full Text] [Related]
10. Surveillance of adverse events following immunisation: Australia, 2000-2002. Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057 [TBL] [Abstract][Full Text] [Related]
11. Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China. Hu Y; Li Q; Lin L; Chen E; Chen Y; Qi X Clin Vaccine Immunol; 2013 Feb; 20(2):211-7. PubMed ID: 23239804 [TBL] [Abstract][Full Text] [Related]
12. Surveillance of adverse events following immunisation: Australia 2002 to 2003. Lawrence G; Boyd I; McIntyre P; Isaacs D Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056 [TBL] [Abstract][Full Text] [Related]
13. Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China. Wang C; Huang N; Lu QB; Black S; Liang X; Cui F Front Immunol; 2022; 13():956473. PubMed ID: 36248783 [TBL] [Abstract][Full Text] [Related]
14. Annual report: surveillance of adverse events following immunisation in Australia, 2007. Lawrence G; Gold MS; Hill R; Deeks S; Glasswell A; McIntyre PB Commun Dis Intell Q Rep; 2008 Dec; 32(4):371-87. PubMed ID: 19374268 [TBL] [Abstract][Full Text] [Related]
15. Annual report: Surveillance of adverse events following immunisation in Australia, 2005. Lawrence G; Boyd I; McIntyre P; Isaacs D Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485 [TBL] [Abstract][Full Text] [Related]
16. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system. Clothier HJ; Hosking L; Crawford NW; Russell M; Easton ML; Quinn JA; Buttery JP Drug Saf; 2015 Jan; 38(1):79-86. PubMed ID: 25475539 [TBL] [Abstract][Full Text] [Related]
17. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015-2018. Hu R; Peng S; Liu Y; Tang F; Wang Z; Zhang L; Gao J; Guo H BMC Public Health; 2021 Jul; 21(1):1338. PubMed ID: 34229643 [TBL] [Abstract][Full Text] [Related]
18. Annual report: Surveillance of adverse events following immunisation in Australia, 2011. Mahajan D; Cook J; Dey A; Macartney K; Menzies RI Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706 [TBL] [Abstract][Full Text] [Related]
19. Application of the revised WHO causality assessment protocol for adverse events following immunization in India. Singh AK; Wagner AL; Joshi J; Carlson BF; Aneja S; Boulton ML Vaccine; 2017 Jul; 35(33):4197-4202. PubMed ID: 28648545 [TBL] [Abstract][Full Text] [Related]
20. Adverse event reporting following immunization of hepatitis B vaccine: A 13-year review. Gong X; Fang Q; Zhong J; Zheng C; Yin Z Hum Vaccin Immunother; 2024 Dec; 20(1):2411824. PubMed ID: 39396824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]